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Abstract
Background: All four Francisella tularensis subspecies possess gene clusters with potential to express type IV pili
(Tfp). These clusters include putative pilin genes, as well as pilB, pilC and pilQ, required for secretion and assembly
of Tfp. A hallmark of Tfp is the ability to retract the pilus upon surface contact, a property mediated by the ATPase
PilT. Interestingly, out of the two major human pathogenic subspecies only the highly virulent type A strains have
a functional pilT gene.
Results: In a previous study, we were able to show that one pilin gene, pilA, was essential for virulence of a type B
strain in a mouse infection model. In this work we have examined the role of several Tfp genes in the virulence of
the pathogenic type A strain SCHU S4. pilA, pilC, pilQ, and pilT were mutated by in-frame deletion mutagenesis.
Interestingly, when mice were infected with a mixture of each mutant strain and the wild-type strain, the pilA, pilC
and pilQ mutants were out-competed, while the pilT mutant was equally competitive as the wild-type.
Conclusions: This suggests that expression and surface localisation of PilA contribute to virulence in the highly
virulent type A strain, while PilT was dispensable for virulence in the mouse infection model.
Background
Francisella tularensis is a Gram-negative facultative
intracellular bacterial pathogen and the causative agent
of tularemia. Infections have been reported in a range of
vertebrates as well as invertebrates [1]. Natural infections
can occur via ingestion of contaminated food or water,
handling of infected animals, bites by infected arthro-
pods, including mosquitoes and ticks, or via inhalation
[2]. F. tularensis is divided into four subspecies, where
ssp. holarctica (type B) is most widely spread and found
in the major part of Europe, Asia, and North America.
F. tularensis ssp. tularensis (type A) is found exclusively
in North America and ssp. mediasiatica in Central Asia.
Finally, ssp. novicida h a sb e e ni s o l a t e di ns e v e r a ll o c a -
tions in North America, as well as in Australia [3,4].
Human infections are mainly caused by type A or type B
strains, where type A strains are significantly more
virulent than type B strains. Our knowledge regarding
virulence determinants in F. tularensis is rather limited.
However, available genome information [5,6] together
with development of genetic tools [7], has resulted in
increased understanding of the molecular mechanisms of
F. tularensis infections.
The genome of F. tularensis encodes gene clusters
involved in secretion and assembly of type IV pili (Tfp)
[5]. Tfp are complex adhesins involved in important host
cell interactions for human pathogens like Neisseria spp.,
Pseudomonas aeruginosa and Vibrio cholerae [8-11]. The
pilus fiber is composed of one major pilin subunit and
several additional minor pilins required for function and/
or assembly of the pilus [12,13]. However, the exact roles
of the minor pilins are still not completely understood.
The pilus is translocated to the cell surface via the secre-
tin, PilQ, which forms a pore in the outer membrane
through which the pilus is transported and extended
[14]. PilD is a peptidase cleaving the prepilin subunits
[11] and PilC is a transmembrane protein spanning
a c r o s st h ep l a s m am e m b r a n e[ 1 5 ] .F u r t h e r m o r e ,t w o
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retraction, of the pilus [16,17]. In some bacteria Tfp can
mediate twitching motility, an activity that is PilT depen-
dent [18].
There is evidence that F. tularensis expresses Tfp-like
surface structures on the bacterial surface [19-21], and
the putative pilin, PilA, has been shown to be required
for virulence of type B strains in a mouse infection
model [22]. Interestingly, due to direct repeat mediated
deletion, the pilA gene has been lost in the attenuated
live vaccine strain LVS [22,23], supporting the signifi-
cance of PilA for virulence [24]. There are also other
potentially significant differences between different
F. tularensis subspecies. In ssp. novicida that is non-
pathogenic for humans, PilA differs in the amino acid
sequence compared to the virulent type A strain SCHU
S4 [25]. On the contrary, pilA of virulent type B strains
is essentially identical to the corresponding gene in type
A strains, however, several other differences are appar-
ent between the two subspecies. Two predicted pilin
genes, pilE and pilV,a n dt h eA T P a s ee n c o d i n gg e n e ,
pilT, are pseudogenes in type B strains [19,21,22,26].
These differences are likely to be significant since pilA
has been linked to virulence of type B strains and is
missing in the attenuated vaccine strain LVS. Further-
more, PilA of ssp. novicida was recently shown to be
involved in protein secretion that was coupled to Tfp
[20,25]. Interestingly, mutation of pilA and loss of pro-
tein secretion resulted in increased virulence in a mouse
infection model [25]. As the human pathogenic type A
and type B strains do not secrete detectable levels of
proteins in vitro,i ti sp o s s i b l et h a to n es t e pi nt h ee v o -
lution of human pathogenic variants of F. tularensis
from ssp. novicida has involved loss of protein secretion
as a consequence of changes in PilA structure and
function.
In this work we wanted to address the question if PilA
is involved in virulence of the highly pathogenic type A
strain SCHU S4, similarly to what we have previously
shown for type B strains, and if Tfp secretion and
assembly genes are required for virulence.
Results
Construction of non-polar pilin gene mutants
In a recent study, we were able to demonstrate that the
pilA gene can be lost by a deletion event mediated by
direct repeats flanking the gene [22]. Type B strains
lacking pilA were found to be attenuated for virulence
in a mouse infection model. In this study we wanted to
extend this work to the highly pathogenic type A strain
SCHU S4, and therefore we constructed a specific pilA
deletion mutant using our previously described allelic
exchange technique [7]. In addition, to address the sig-
nificance of secretion and assembly of PilA, we also
engineered in-frame deletions in pilC and pilQ,e n c o d -
ing a transmembrane protein and a secretin, respec-
tively. For some pathogens, Tfp expression is associated
with a unique ability to retract the pili, a phenotype
depending on the ATPase PilT. Interestingly, pilT
appears to be functional in type A strains, while it is a
pseudogene in the less pathogenic type B strains. In
order to elucidate if the expression of PilT could be cor-
related to the higher virulence of type A strains, we also
constructed an in-frame deletion in the pilT gene.
In order to verify that the mutations did not have a
major impact on neighboring gene transcription, each
region was analysed by RT-PCR on mRNA extracted
from the mutant strains and compared to the isogenic
wild-type strain (Fig. 1). Thereby we could confirm that
none of the deletion events caused any polar effects on
transcription. Both pilC and pilT are flanked by pseudo-
genes situated directly downstream of each gene that
were found not to be transcribed neither in the wild-
type nor in the pilC or pilT mutant strains. The
upstream genes of pilC and pilT were readily tran-
scribed at similar levels in the wild-type and mutant
strains. In the case of the pilQ mutant, we could verify
non-polarity on the downstream aroK gene.
We also attempted to make an in-frame deletion of
the pilA gene, but in spite of several attempts we were
unable to generate an unmarked deletion. It is possible
that this is linked to the fact that there are two direct
repeats flanking pilA and that this somehow affects the
recombination in this region [22]. We therefore chose a
different strategy where we introduced a chlorampheni-
col resistance gene to allow for direct selection of the
mutational event. In order to lower the risk of polar
effects on the downstream pilE gene the resistance gene
was inserted in the same orientation as the pilAE genes.
We could also verify that the levels of pilE transcription
were similar in the pilA mutant and wild-type strain,
suggesting that there were no major polar effects on
downstream genes. We have previously shown that pilV
is transcribed from a promoter downstream of pilE gene
in type strains [22] and also in this case pilV transcrip-
tion levels were similar in the pilA and the wild-type
strain. From this we conclude that none of the muta-
tions generated any major polar effect on transcription
of neighboring genes.
PilA expression in Tfp mutant strains
Next we wanted to address if any of the mutations influ-
enced PilA expression. Therefore the expression of PilA
in the different mutant strains was analysed by Western
blot analysis. All mutants, except for pilA, expressed
PilA at levels similar to the isogenic wild-type strain
SCHU S4 (Fig. 2). The apparent molecular mass of PilA
was similar to what has previously been shown for type
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lated molecular masses, indicating PilA to be post-tran-
scriptionally modified, presumably by glycosylation [22].
Thus, with the exception of the pilA mutant, all the
mutants expressed PilA at similar levels as the wild-type
strain SCHU S4.
pilA, pilC and pilQ contribute to virulence of SCHU S4
When we studied the role of pilA in LVS we could
establish that the pilin had a major impact on virulence
[24]. More recently, we have also made a specific pilA
mutant in a recent clinical type B isolate. In this highly
virulent type B strain, the attenuation seen for the pilA
mutant was less marked, but still the lethal infection
dose for the mutant was about 40-fold higher compared
to the isogenic wild-type strain (unpublished data).
Here, we wanted to address the role of pilA, the assem-
bly/secretion genes, pilC and pilQ,a n dt h eA T P a s e
encoding gene pilT, in the virulence of the highly patho-
genic type A strain SCHU S4. First we verified that the
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Figure 1 A-D. Analysis of gene transcription in wild-type and mutant strains of F. tularensis using RT-PCR of mRNA. The location of the
different primers used is indicated by small arrows. Large arrows illustrate direction of transcription. Control reactions where reverse transcriptase
was omitted were all negative (data not shown).
Figure 2 PilA is expressed at wild-type levels in all strains,
except for the pilA deletion mutant. Different pili mutants in the
F. tularensis strain SCHU S4, analysed by Western blot using an anti-
PilA antiserum. Lane; 1, FSC237 (SCHU S4, Type A); 2, FSC237 pilC
deletion mutant; 3, FSC237 pilT deletion mutant; 4, FSC237 pilQ
deletion mutant; 5, FSC237 pilA deletion mutant; 6, FSC200 (Type B).
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strains by measuring growth in liquid medium (data not
shown). In order to evaluate the importance of the pili
genes for in vivo virulence, mice were infected via the
subcutaneous (s.c.) route with the mutant strains, as
well as the isogenic wild-type strain SCHU S4. We used
the s.c. route of infection as it can be more discrimina-
tive than the intraperitoneal (i.p.) route of infection. For
instance, the attenuated vaccine strain LVS is still viru-
lent by the i.p. route but highly attenuated by the s.c.
route of infection in mice. Two different infection doses
were used; approximately 10 and 100 bacteria respec-
tively. Groups of six mice were infected with each dose
and the progress of the infection was monitored over
time. Small differences in infection kinetics were
observed for the pilA, pilC and pilQ mutants, and mice
infected with these strains showed a slightly delayed
time to death compared to mice infected with the wild-
type strain. Still, as SCHU S4 is very virulent in mice,
even at the lowest doses (5 - 10 bacteria), all animals
had succumbed to the infection after six to eight days
post infection, making it difficult to establish the signifi-
cance of the result (Fig. 3, Table 1). Therefore, we
decided to perform competitive infections between the
wild-type strain and the different isogenic mutants. In
this case all mutants, except pilT, were out-competed by
the wild-type strain SCHU S4. For the pilA, pilC and
pilQ mutant strains, the ratios were 0.14, 0.34 and 0.16
(Table 1), respectively, suggesting PilA to be a virulence
determinant also in the type A strain SCHU S4. The
fact that the ratio was similar for the pilC and pilQ
mutants indicate that assembly/surface localisation of
the pilin PilA is required for full virulence in the mouse
infection model. Statistical analysis verified that the dif-
ferences in ratios for these three mutants were signifi-
cant at P < 0.05 (data not shown). Somewhat
surprisingly, the pilT mutant was not out-competed by
the wild-type strain in the mixed infection experiment.
The ratio (1.98) suggests that PilT is dispensable for
virulence in the subcutaneous mouse infection model
(Table 1). In this case the higher ratio for the pilT
mutant was not statistically significant (data not shown).
Discussion
Recently, we have provided evidence that PilA, one of
the type IV pilins encoded by the human pathogenic
subspecies of F. tularensis, is an important virulence
determinant for type B strains [22]. In addition, we have
established that loss of the pilA gene is one of two
major genetic events, responsible for the attenuation of
the live vaccine strain, LVS [6,24]. Even though we have
been able to demonstrate PilA to be both surface
located in F. tularensis [22] and able to form functional
Tfp in the heterologous system in Neisseria gonorrhoeae
[27], we have still not managed to verify PilA to be an
actual structural component of Tfp expressed by
F. tularensis.
In this study, we present evidence that PilA and the
Tfp assembly/secretion proteins, PilC and PilQ, are
required for full virulence of the type A strain, SCHU
S4, the most virulent subspecies of F. tularensis.I n
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Figure 3 Infection kinetics are slightly delayed for mice infected with the pilA, pilC,a n dpilQ deletion strains. Groups of six mice were
infected via the subcutaneous route and the survival followed over time. The exact dose for each strain was determined by retrospective viable
count.
Table 1 Mice infection data
SCHU S4 Infection dose
(cfu)
CI value
wt 11
pilA 4.8 0.14
pilC 8.5 0.34
pilT 6.0 1.98
pilQ 10 0.16
Infection dose (cfu) in a standard infection study, and CI value in a
competitive index assay.
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show that mutations of the putative Tfp genes resulted
in a significant attenuation. However, when we con-
ducted mixed infections, where the ability of the
mutants to compete with the wild-type strain was
assessed, it became more obvious that Tfp encoding
genes may play a role in the virulence of SCHU S4. This
is in line with our observation that pilA mutants in
highly virulent clinical isolates of type B strains are less
attenuated compared to type B strains with weaker viru-
lence, like LVS [22,24]. A general problem with the
mouse infection model is that mice are highly suscepti-
ble to Francisella and do not discriminate between the
virulence properties of different F. tularensis subspecies
in the same way as the human infection. The emerging
picture is that pilA mutants show less attenuation in the
most pathogenic subspecies. Still, we believe that PilA,
and potentially also Tfp, may play an important role in
virulence. This theory is supported by the fact that LVS
has lost pilA, and that this is one of the causes of its
attenuation [24]. When genomes of different subspecies
are compared, one striking difference is that the pilT
g e n ei sap s e u d o g e n ei nt y p eBs t r a i n s ,d u et oap o i n t
mutation introducing a stop codon in the middle of the
gene [26]. Interestingly, in a study involving the attenu-
ated type B strain LVS the pilT gene was demonstrated
to be involved in pili assembly, adherence and virulence
[19]. Chakraborty with colleagues have suggested the
possibility that the truncated PilT protein somehow has
retained function in LVS [19]. Their findings are some-
what surprising since in other Tfp expressing pathogens
the PilT protein is only involved in pilus retraction and
not in pilus assembly. The pilT mutant in SCHU S4 did
not have any impact on the virulence in the subcuta-
neous mouse infection model. However, the fact that
pilT is intact in most pathogenic type A strains suggests
that PilT might, at least partly, contribute to the higher
virulence of type A strains. As mentioned above, this
infection model has limitations and may not reflect viru-
lence in humans. Another possibility is that PilT may
rather play a role in the environment and/or in trans-
mission of tularemia than in the animal/human infec-
tion. With the genetic tools and the availability of
specific mutants in the Tfp encoding gene clusters of
SCHU S4, it will now be possible to address the role of
the Tfp system in other infection models, for survival in
the environment, and perchance for vector-borne
transmission.
Conclusions
We have shown that pilA is required for full virulence
of SCHU S4 in mice - a result in line with our earlier
findings in type B strains. In addition, we have also
demonstrated that the pilin assembly genes, pilC and
pilQ, are needed for full virulence of SCHU S4. An
unexpectedly finding is that PilT, even though it is func-
tional only in type A strains, did not contribute to viru-
lence in the mouse subcutaneous infection model.
Methods
Bacterial strains, plasmids, growth conditions, and DNA
methods
The bacterial strains and plasmids used in this study are
listed in Table 2. F. tularensis strains were grown on modi-
fied Thayer-Martin agar or Blood Cystine Glucose agar
(BCGA) at 37ºC in 5% CO2. Escherichia coli strains were
grown on blood agar base (BAB; Merck) plates or in Luria
Bertani broth (LB). Antibiotics were used at the following
concentrations: kanamycin 50 μg/ml and chloramphenicol
2.5 μg/ml (F. tularensis), or 25 μg/ml (E. coli). Preparation
of plasmid DNA, restriction enzyme digests, ligations and
transformations into E. coli were performed essentially
as described [28]. Generally, the primers (Table 3) were
constructed based on the genomic information from
the FSC237 (SCHU S4) and FSC155 (LVS) genomes. The
amplified PCR fragments were first cloned into the
pCR®4.0-TOPO cloning vector (Invitrogen AB, Stockholm,
Sweden), sequenced by Eurofins MWG Operon, and sub-
sequently cloned into the suicide vectors pSMP22 [29] or
pDM4 [30].
Construction of deletion mutants of pilA, pilC, pilQ, and
pilT in FSC237
Left and right flanking regions of pilA (FTT0890c,
SCHU S4 nomenclature) were PCR amplified using the
primer pairs pilA_LFF/pilA_LFR and pilA_RFF/
pilA_RFR, and cloned into pGEMT-easy (Promega). The
left flank was excised with EcoRI and PstI and the right
flank was excised with BamHI and PstI. The fragments
were ligated into an EcoRI/BamHI digested pBluescript
KS+ vector (Stratagene), giving rise to pSMP47. A chlor-
amphenicol resistance gene was PCR amplified from
pDM4 with the primer pair CAM_PstIF/CAM_PstIR,
digested with PstI, and cloned into pSMP47, generating
pSMP48 containing the left and right flanks of pilA dis-
rupted by a chloramphenicol cassette. The mutated
allele of pilA was excised from pSMP48 with SphI and
MluI, cloned into pSMP22, and the resulting plasmid
pSMP50CAM (Table 2) was introduced into strain
FSC237 by conjugal mating as previously described [7].
The deletion constructs for pilC, pilQ and pilT were
obtained by overlapping PCR using the following primer
pairs PilX_A, PilX_B, PilX_C and PilX_D (Table 3). For
the deletion constructs of pilC and pilQ strain FSC237
was used as template and for the pilT deletion the strain
FSC155 was used as a template. The sequence for the
pilT construct is almost identical between FSC155 and
FSC237 except for three substitutions upstream of the
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tions in a downstream pseudogene. The PCR fragments
were cloned into the suicide vector pDM4 and the
resulting plasmids pAL12 (pilC), pAL16 (pilQ), and
pAL18 (pilT) (Table 2) were introduced into strain
FSC237 by conjugal mating as previously described [7].
The in vitro growth rate of the different mutant strains
were compared with the wild type strain by measuring
OD at different time points, 0 h, 6 h and ON after dilu-
tion in Chamberlain medium.
RNA isolation and RT-PCR
Bacteria were grown for 18 h on plates, harvested and
suspended in TRIzol reagent (Life Technologies). Total
RNA was extracted and treated with RNase-free DNase
I (Roche), phenol extracted, and precipitated by ethanol.
An aliquot of the RNA (3 μg) was used to synthesize
cDNA using random hexamers (final concentration 25
ng/μl) and Superscript III reverse transcriptase as
described by the manufacturer (Life Technologies). In
control experiments samples processed without addition
of RT enzyme were used.
Animal infections
F. tularensis strains were grown for 16 h on BCGA
before the bacteria were suspended in phosphate buf-
fered saline (PBS) pH 7.4 to an OD540 =1 ,w h i c hn o r -
mally corresponds to approximately 2 × 10
9 bacteria/ml.
The bacterial suspension was then diluted in PBS into
two doses used for challenge, around 10 and 100 bac-
teria in a total volume of 100 μl. All bacterial infections
were initiated by subcutaneous injections of 6-8 week
old C57Black/6 female mice. The study was approved by
the Local Ethical Committee on Laboratory Animals in
Umeå, Sweden. For competitive index (CI) infections,
t h em i c ew e r ei n f e c t e dw i t ha5 0 : 5 0m i x t u r eo fm u t a n t
and wild-type strains with around 50 bacteria of each
strain. Mice were culled five days post-infection, and the
spleens were homogenized in 1 ml of PBS and spread
on BCGA. Individual colonies were analysed by PCR
with primers specific for each mutation in order to
examine the distribution of each strain. Spleens from at
least three animals were collected for each pair of
strains, and at least 200 colonies were analysed by PCR.
The CI was calculated for each strain by dividing the
ratio of mutant/wt after infection (determined with
PCR) with the ratio of mutant/wt before infection
(determined by viable count). Statistical analysis was
performed with a GraphPad Prism computer software
p r o g r a mu s i n gap a i r e dS t u d e n t ’s t-test (one-tailed)
where P < 0.05 was regarded as significant.
Gel electrophoresis and Western blotting
Samples were boiled in the presence of SDS and Β-mer-
captoethanol for 5 min and then separated on a 12%
acrylamide gel by electrophoresis as described by
Laemmli [31]. Proteins were transferred to Immobilon-P
Transfer Membranes using aT r a n s - B l o tS e m i - D r y
Table 2 Strains and plasmids used in this study
Strains Genotype/phenotype Source
F. tularensis
FSC237 tularensis; SCHU S4 Human ulcer 1941,
Ohio
FSC237; ΔpilA; deletion of codons 1-135 This study
FSC237; ΔpilC (FTT1134); in frame deletion of codons 5-405 This study
FSC237; ΔpilQ (FTT1156); in frame deletion of codons 13-593 This study
FSC237; ΔpilT (FTT0088); in frame deletion of codons 7-336 This study
E. coli
Top10 F
- mcrA Δ(mrr-hsdRMS-mcrBC), F80lacZΔM15 ΔlacX74 recA1 deoR araD139 (Δara-leu)7697 galU galK rpsL (Sm
r)
endA1 nupG
Invitrogen
S17-1Λpir recA, thi, pro, hsdR
-M+,<RP4:2-Tc:Mu:Km:Tn7>T p
R,S m
R [32]
Plasmids
pCR®4.0 TOPO-cloning vector. Amp
R,K m
R Invitrogen
pDM4 Suicide plasmid. sacB; mobRP4; oriR6K; Cm
R [30]
pSMP22 Suicide plasmid. groESL promoter, ori T, bla, sacB [29]
pSMP50CAM 432 bp fragment of pilA including a chlorampenicol resistance cassette cloned into pSMP22. Cm
R This study
pAL12 2072 bp fragment of approximately 1 kb upstream and 1 kb downstream of pilC cloned in XbaI and SalI site
of pDM4. Cm
R
This study
pAL16 2122 bp fragment of approximately 1 kb upstream and 1 kb downstream of pilQ cloned in XbaI and SalI site
of pDM4. Cm
R
This study
pAL18 2133 bp fragment of approximately 1 kb upstream and 1 kb downstream of pilT cloned in XbaI and SalI site of
pDM4. Cm
R
This study
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Page 6 of 8transfer cell (BioRad). Membranes were blocked over-
night in Tris-buffered saline (TBS) with 5% nonfat dry
milk. Membranes were probed with rabbit polyclonal
anti-PilA sera [22] and a horseradish peroxidase-conju-
gated anti rabbit antibody (Amersham Pharmacia Bio-
tech) was used as secondary antibody and the filters
were developed by using the ECL Kit (Amersham
Pharmacia Biotech) according to the instructions from
the manufacturer.
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